More on Quest Diagnostics (DGX -4.1%) Q2: net profit +9% to $178M, helped by lower expenses as...

|About: Quest Diagnostics Incorpo... (DGX)|By:, SA News Editor

More on Quest Diagnostics (DGX -4.1%) Q2: net profit +9% to $178M, helped by lower expenses as revenue barely rises. Cuts FY sales growth outlook to 1%-2% from 2%-2.5% prior but maintains EPS outlook at $4.45-$4.60 vs. consensus of $4.60. Also lowers cap-spending plans to $200M from $200M-$225M prior.